X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3090) 3090
Publication (307) 307
Book Review (49) 49
Book Chapter (39) 39
Conference Proceeding (7) 7
Dissertation (2) 2
Magazine Article (2) 2
Reference (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
alemtuzumab (2752) 2752
humans (2436) 2436
index medicus (1502) 1502
male (1192) 1192
antibodies, monoclonal, humanized (1139) 1139
female (1134) 1134
middle aged (958) 958
antibodies, monoclonal - therapeutic use (936) 936
adult (909) 909
hematology (860) 860
transplantation (849) 849
antibodies, neoplasm - therapeutic use (741) 741
treatment outcome (644) 644
oncology (634) 634
aged (604) 604
rituximab (575) 575
immunology (528) 528
antineoplastic agents - therapeutic use (523) 523
immunosuppressive agents - therapeutic use (471) 471
therapy (467) 467
multiple sclerosis (408) 408
antibodies, monoclonal, humanized - therapeutic use (399) 399
leukemia, lymphocytic, chronic, b-cell - drug therapy (399) 399
campath-1h (387) 387
monoclonal antibodies (357) 357
surgery (347) 347
fludarabine (329) 329
antibodies, monoclonal - adverse effects (312) 312
antibodies, monoclonal - administration & dosage (304) 304
adolescent (289) 289
animals (288) 288
retrospective studies (277) 277
antibodies, neoplasm - adverse effects (267) 267
immunotherapy (265) 265
chronic lymphocytic-leukemia (261) 261
antibodies, neoplasm - administration & dosage (259) 259
antineoplastic combined chemotherapy protocols - therapeutic use (253) 253
care and treatment (248) 248
clinical neurology (247) 247
risk factors (246) 246
transplantation, homologous (243) 243
vidarabine - analogs & derivatives (240) 240
cd52 antigen (239) 239
chronic lymphocytic leukemia (231) 231
health aspects (231) 231
stem-cell transplantation (231) 231
immunosuppression (225) 225
bone-marrow-transplantation (224) 224
follow-up studies (216) 216
young adult (206) 206
drug therapy (202) 202
stem cells (199) 199
research (194) 194
kidney transplantation (192) 192
transplantation conditioning - methods (189) 189
t cells (187) 187
leukemia (186) 186
graft rejection - prevention & control (185) 185
medicine & public health (184) 184
disease (183) 183
cancer (177) 177
child (173) 173
antibodies, monoclonal, murine-derived (172) 172
recurrence (171) 171
pharmacology & pharmacy (170) 170
recipients (167) 167
survival (167) 167
time factors (166) 166
versus-host-disease (165) 165
antineoplastic agents - adverse effects (164) 164
chemotherapy (164) 164
hematopoietic stem cell transplantation (162) 162
antibodies, monoclonal, humanized - administration & dosage (161) 161
prognosis (161) 161
aged, 80 and over (158) 158
hematology, oncology and palliative medicine (158) 158
abridged index medicus (156) 156
clinical trials as topic (156) 156
cyclophosphamide (156) 156
hematopoietic stem cells (156) 156
antigens, cd - immunology (155) 155
remission induction (155) 155
antineoplastic agents - administration & dosage (152) 152
natalizumab (152) 152
multiple sclerosis - drug therapy (151) 151
analysis (150) 150
antibodies, monoclonal - pharmacology (145) 145
graft survival (144) 144
graft vs host disease - prevention & control (143) 143
monoclonal-antibody (143) 143
antibodies, monoclonal, humanized - adverse effects (139) 139
article (139) 139
kidneys (139) 139
disease-free survival (138) 138
stem cell transplantation (135) 135
cll (134) 134
immunosuppressive agents - adverse effects (134) 134
survival rate (134) 134
renal-transplantation (132) 132
antineoplastic agents (131) 131
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2914) 2914
German (57) 57
French (43) 43
Spanish (28) 28
Japanese (15) 15
Polish (14) 14
Russian (14) 14
Hungarian (11) 11
Czech (10) 10
Chinese (6) 6
Danish (2) 2
Korean (2) 2
Norwegian (2) 2
Portuguese (2) 2
Slovenian (2) 2
Bosnian (1) 1
Dutch (1) 1
Finnish (1) 1
Italian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BRITISH JOURNAL OF DERMATOLOGY, ISSN 0007-0963, 01/2018, Volume 178, Issue 1, pp. 303 - 303
Journal Article
Transplantation, ISSN 0041-1337, 04/2003, Volume 75, Issue 8, pp. 1227 - 1231
Background. The aim of this research was to study the efficacy of campath 1H in combination with low-dose tacrolimus immunosuppression for intestinal,... 
alemtuzumab
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 02/2019, Volume 60, Issue 3, pp. 563 - 565
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2017, Volume 23, Issue 1, pp. 35 - 42
Purpose: Therapeutic regimens for adult T-cell leukemia/lymphoma (ATL) are limited with unsatisfactory results, thereby warranting development of novel... 
MURINE MODEL | PROLYMPHOCYTIC LEUKEMIA | INTERFERON-ALPHA | HUMAN CD52 ANTIBODY | ONCOLOGY | NON-HODGKINS-LYMPHOMAS | CHRONIC LYMPHOCYTIC-LEUKEMIA | PERIPHERAL-BLOOD | EFFECTIVE THERAPY | SEZARY-SYNDROME | ANTI-CD52 MONOCLONAL-ANTIBODY | Antineoplastic Agents, Immunological - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - diagnosis | Alemtuzumab - adverse effects | Humans | Middle Aged | Male | Human T-lymphotropic virus 1 | Young Adult | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Adult | Female | Alemtuzumab - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - mortality | Kaplan-Meier Estimate | Immunophenotyping | Treatment Outcome | HTLV-I Infections - virology | Retreatment | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Agents, Immunological - therapeutic use | Leukemia-Lymphoma, Adult T-Cell - etiology | Aged | Neoplasm Staging | Alemtuzumab - therapeutic use | HTLV-I Infections - complications | Thrombocytopenia | Cytomegalovirus | Intravenous administration | Cell survival | Leukopenia | Anemia | Toxicity | Leukemia | Viruses | Lymphocytes T | Survival | Patients | Lymphoma | Anticancer properties | Confidence intervals | Experimental design | Monoclonal antibodies | Antigenemia | Antitumor activity | Lymphomas | Cancer | Neutropenia | leukemia | HTLV-1 | Alemtuzumab | T-cell | lymphoma
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 03/2018, Volume 19, Issue 5, pp. 483 - 498
Introduction: Multiple sclerosis (MS) is an immune-mediated and neurodegenerative disease with an unpredictable outcome. Immune-modulatory treatment aims at... 
interferon beta | Multiple sclerosis | ocrelizumab | dimethylfumarate | alemtuzumab | cladribine | fingolimod | teriflunomide | glatiramer acetate | natalizumab | daclizumab | HIGH-YIELD PROCESS | CONTROLLED PHASE-3 | GRANULE CELL NEURONOPATHY | FUMARIC-ACID ESTERS | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | VARICELLA-ZOSTER-VIRUS | INTERFERON-BETA THERAPY | TERM-FOLLOW-UP | PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | DISEASE-MODIFYING THERAPIES | Alemtuzumab - adverse effects | Neoplasms - etiology | Crotonates - metabolism | Alemtuzumab - metabolism | Humans | Immunosuppressive Agents - therapeutic use | Natalizumab - adverse effects | Natalizumab - metabolism | Interferon-beta - therapeutic use | Interferon-beta - adverse effects | Natalizumab - therapeutic use | Fingolimod Hydrochloride - adverse effects | Fingolimod Hydrochloride - therapeutic use | Toluidines - therapeutic use | Toluidines - metabolism | Toluidines - adverse effects | Fingolimod Hydrochloride - metabolism | Crotonates - therapeutic use | Glatiramer Acetate - adverse effects | Cladribine - metabolism | Interferon-beta - metabolism | Cladribine - therapeutic use | Glatiramer Acetate - therapeutic use | Multiple Sclerosis - pathology | Glatiramer Acetate - metabolism | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Cladribine - adverse effects | Crotonates - adverse effects | Alemtuzumab - therapeutic use | Immunologic Factors - therapeutic use | Multiple Sclerosis - drug therapy
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 2018, p. 135245851881026
Journal Article
Journal of Neurology, ISSN 0340-5354, 12/2018, Volume 265, Issue 12, pp. 2851 - 2860
Journal Article
Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, ISSN 1997-7298, 2018, Volume 118, Issue 8, pp. 82 - 87
Journal Article
Journal of Neurology, ISSN 0340-5354, 1/2019, Volume 266, Issue 1, pp. 165 - 173
Journal Article